To investigate whether the upregulation of COL4A1 expression induced poor prognosis in LGG, PAAD, SKCM, and STAD by modulating the immune landscape in the TME, we analyzed the association between COL4A1 expression and infiltration of immune cells into the TME. The gene discussed is COL4A1; the disease is pancreatic adenocarcinoma.